stock.name

BridgeBio Pharma Inc

BBIO

Market Cap$5.43B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BridgeBio Pharma IncBridgeBio Pharma Inc-10.10%51%27.1-1.6
$47.50

Target Price by Analysts

75.6% upsideBridgeBio Pharma Target Price DetailsTarget Price
$-9.02

Current Fair Value

133.3% downside

Overvalued by 133.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$5.43 Billion
Enterprise Value$6.62 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-3.18
Beta0.0
Outstanding Shares187,129,260
Avg 30 Day Volume1,741,536

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-10.08
PEG13.47
Price to Sales27.05
Price to Book Ratio-4.51
Enterprise Value to Revenue30.3
Enterprise Value to EBIT-14
Enterprise Value to Net Income-13
Total Debt to Enterprise0.26
Debt to Equity-1.63

Revenue Sources

No data

Insider Trades

ESG Score

No data

About BridgeBio Pharma Inc

CEO: Neil Kumar